This brand name is authorized in United States
The drug CNJ-016 contains one active pharmaceutical ingredient (API):
|
1
Vaccinia immunoglobulin
UNII 7UB4J759TD - HUMAN VACCINIA VIRUS IMMUNE GLOBULIN
|
|
Vaccinia immunoglobulin provides passive immunity for individuals with complications to vaccinia virus vaccination. The exact mechanism of action is not known. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| CNJ-016 Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 60492-0173 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
